Aurinia Pharmaceuticals (AUPH)
NASDAQ:AUPH
Holding AUPH?
Track your performance easily

Aurinia Pharmaceuticals (AUPH) Financial Statements

1,944 Followers

Aurinia Pharmaceuticals Financial Overview

Aurinia Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.35; its P/E ratio is -20.19; Aurinia Pharmaceuticals is scheduled to report earnings on October 31, 2024, and the estimated EPS forecast is $0.01. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 57.19M$ 50.30M$ 45.09M$ 54.52M$ 41.49M
Gross Profit$ 48.28M$ 42.55M$ 39.70M$ 47.75M$ 39.93M
EBIT$ 2.68M$ -8.73M$ -25.75M$ -11.75M$ -11.43M
EBITDA$ 4.39M$ -7.09M$ -24.10M$ -11.75M$ -13.70M
Net Income Common Stockholders$ 722.00K$ -10.75M$ -26.88M$ -13.45M$ -11.49M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 330.48M$ 319.91M$ 350.49M$ 337.90M$ 350.71M
Total Assets$ 523.53M$ 516.63M$ 548.06M$ 555.01M$ 548.90M
Total Debt$ 85.98M$ 88.54M$ 97.61M$ 93.21M$ 101.21M
Net Debt$ -244.49M$ -231.38M$ -252.88M$ -244.69M$ -249.51M
Total Liabilities$ 158.91M$ 157.16M$ 170.11M$ 163.14M$ 156.61M
Stockholders Equity$ 364.62M$ 359.48M$ 377.95M$ 391.88M$ 392.29M
Cash Flow-
Free Cash Flow$ 15.76M$ -18.61M$ 14.25M-$ -3.05M
Operating Cash Flow$ 15.84M$ -18.60M$ 14.31M-$ -2.83M
Investing Cash Flow$ -38.62M$ 49.23M$ -6.26M-$ -5.61M
Financing Cash Flow$ -8.27M$ -15.05M$ -5.58M-$ 1.14M
Currency in USD

Aurinia Pharmaceuticals Earnings and Revenue History

Aurinia Pharmaceuticals Debt to Assets

Aurinia Pharmaceuticals Cash Flow

Aurinia Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis